Evaluation of Postoperative Long-Term Quality of Life after Laparoscopic Anterior Partial Fundoplication in the Treatment of Gastroesophageal Reflux Disease

2009 ◽  
Vol 26 (5) ◽  
pp. 413-417 ◽  
Author(s):  
Wieland Raue ◽  
Charalambos Menenakos ◽  
Chris Braumann ◽  
Diana Trache ◽  
Jens Hartmann
Keyword(s):  
Quality Of Life ◽  
Gastroesophageal Reflux Disease ◽  
Gastroesophageal Reflux ◽  
Reflux Disease ◽  
Partial Fundoplication ◽  
Anterior Partial Fundoplication

scholarly journals Long-Term Benefits of Smoking Cessation on Gastroesophageal Reflux Disease and Health-Related Quality of Life

PLoS ONE ◽  
2016 ◽  
Vol 11 (2) ◽  
pp. e0147860 ◽  
Author(s):  
Yukie Kohata ◽  
Yasuhiro Fujiwara ◽  
Takanori Watanabe ◽  
Masanori Kobayashi ◽  
Yasuhiko Takemoto ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Smoking Cessation ◽  
Gastroesophageal Reflux Disease ◽  
Gastroesophageal Reflux ◽  
Reflux Disease ◽  
Health Related Quality ◽  
Related Quality ◽  
Health Related

The Impact of Laparoscopic Nissen Fundoplication on the Long-Term Quality of Life in Patients With Gastroesophageal Reflux Disease

2015 ◽  
Vol 38 (2) ◽  
pp. 111-115 ◽  
Author(s):  
Dimitrios P. Korkolis ◽  
Maria Kapritsou ◽  
Evangelos A. Konstantinou ◽  
Margaret Giannakopoulou ◽  
Maria S. Chrysi ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Gastroesophageal Reflux Disease ◽  
Gastroesophageal Reflux ◽  
Reflux Disease ◽  
Nissen Fundoplication ◽  
Laparoscopic Nissen Fundoplication ◽  
Laparoscopic Nissen ◽  
The Impact

scholarly journals Correction: Long-Term Benefits of Smoking Cessation on Gastroesophageal Reflux Disease and Health-Related Quality of Life

PLoS ONE ◽  
2016 ◽  
Vol 11 (3) ◽  
pp. e0150554
Author(s):  
Yukie Kohata ◽  
Yasuhiro Fujiwara ◽  
Takanori Watanabe ◽  
Masanori Kobayashi ◽  
Yasuhiko Takemoto ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Smoking Cessation ◽  
Gastroesophageal Reflux Disease ◽  
Gastroesophageal Reflux ◽  
Reflux Disease ◽  
Health Related Quality ◽  
Related Quality ◽  
Health Related

scholarly journals Magnetic sphincter augmentation device removal: surgical technique and results at medium-term follow-up

2021 ◽  
Author(s):  
Davide Bona ◽  
Greta Saino ◽  
Emanuele Mini ◽  
Francesca Lombardo ◽  
Valerio Panizzo ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Gastroesophageal Reflux Disease ◽  
Gastroesophageal Reflux ◽  
Reflux Disease ◽  
Hospital Length Of Stay ◽  
Partial Fundoplication ◽  
Magnetic Sphincter Augmentation ◽  
Sf 36

Abstract Background The magnetic sphincter augmentation (MSA) device has become a common option for the treatment of gastroesophageal reflux disease (GERD). Knowledge of MSA-related complications, indications for removal, and techniques are puzzled. With this study, we aimed to evaluate indications, techniques for removal, surgical approach, and outcomes with MSA removal. Methods This is an observational singe-center study. Patients were followed up regularly with endoscopy, pH monitoring, and assessed for specific gastroesophageal reflux disease health-related quality of life (GERD-HRQL) and generic short-form 36 (SF-36) quality of life. Results Five patients underwent MSA explant. Four patients were males and the median age was 47 years (range 44–55). Heartburn, epigastric/chest pain, and dysphagia were commonly reported. The median implant duration was 46 months (range 31–72). A laparoscopic approach was adopted in all patients. Intraoperative findings included normal anatomy (40%), herniation in the mediastinum (40%), and erosion (20%). The most common anti-reflux procedures were Dor (n = 2), Toupet (n = 2), and anterior partial fundoplication (n = 1). The median operative time was 145 min (range 60–185), and the median hospital length of stay was 4 days (range 3–6). The median postoperative follow-up was 41 months (range 12–51). At the last follow-up, 80% of patients were off PPI; the GERD-HRQL and SF-36 questionnaire were improved with DeMeester score and esophageal acid exposure normalization. Conclusion The MSA device can be safely explanted through a single-stage laparoscopic procedure. Tailoring a fundoplication, according to preoperative patient symptoms and intraoperative findings, seems feasible and safe with a promising trend toward improved symptoms and quality of life.

scholarly journals Endoscopic polymer injection and endoluminal plication in treatment of gastroesophageal reflux disease: evaluation of long-term results

2018 ◽  
Vol 06 (05) ◽  
pp. E630-E636 ◽  
Author(s):  
Eduardo De Moura ◽  
Rubens Sallum ◽  
Ary Nasi ◽  
Martin Coronel ◽  
Diogo De Moura ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Gastroesophageal Reflux Disease ◽  
Gastroesophageal Reflux ◽  
Reflux Disease ◽  
Endoscopic Treatment ◽  
Short Term ◽  
Polymer Injection ◽  
Number Of Patients

Abstract Background and study aims Us of proton pump inhibitors (PPIs) has made endoscopic treatment of gastroesophageal reflux disease (GERD) more efficient, with reduction in morbidity and complications. However, some patients persist with symptoms despite medical treatment and some are not compliant with it or cannot afford it for financial reasons, and thus they require non-pharmacological therapeutic options such as surgical fundoplication. Surgery may be effective in the short term, but there is related morbidity and concern about its long-term efficacy. The possibility of minimally invasive endoluminal surgeries has resulted in interest in and development of newly endoscopic devices. Good short-term results with surgical fundoplication lack of studies of is with long follow-up justify our interest in this study. The aim of this study was to investigate the efficacy of endoscopic polymer injection and endoluminal full-thickness plication in the long-term control of GERD. Patients and methods Forty-seven patients with GERD who underwent an endoscopic procedure were followed up for 60 months and evaluated for total response (RT), partial response (RP) and no response (SR) to endoscopic treatment with reintroduction of PPIs. Results Twenty-one patients received polymer injection (G0) and 26 endoluminal plication (G1). The number of patients with no response to endoscopic treatment with reintroduction of PPIs increased in time for both techniques (G0 P = 0.006; G1 P < 0.001). There was symptomatic improvement up to 12 months, with progressive loss of this trending up to 60 months in G0 and G1 (P < 0.001). Health-related quality of life score (GERD-HRQL) demonstrated TR in G0 and G1 at 1, 3, 6 and 12 months. The 60-month analysis showed an increased number of patients with SR in both groups. The quality of life assessment (SF-36) showed benefit in G0 up to 3 months. G0 showed a higher rate of complications. There were no deaths. There was healing of esophagitis at 3 months in 45 % of patients in G0 and 40 % in G1. There was no improvement in manometric or pH findings. Conclusion Endoscopic therapies were ineffective in controlling GERD in the long term.

Sign in / Sign up

Export Citation Format

Share Document